NOG (NOG)

$3.1B
Market Cap
77.1
P/E Ratio
1.01
Beta
5.84%
Dividend Yield
Piotroski 6/9Altman Z 1.2 DistressBeneish M -2.71 CleanROIC−WACC -4.2%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.2.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of the company reveal a significant divergence between capital efficiency and profitability generation. A negative ROIC-WACC spread of -4.2% indicates that the firm is currently destroying value by deploying capital at rates lower than its cost, a concern amplified by an Altman Z-Score of 1.2 which flags potential financial distress risk despite a respectable Piotroski F-Score of 6/9 suggesting stable fundamentals over the last nine months. This weakness in return on invested capital is mirrored in the DuPont decomposition, where a mere 1.8% net margin constrains returns even as asset turnover sits at 0.39x and leverage multiplies equity by 2.54x; while gross margins remain robust at 32.2%, declining revenue growth of -3.2% year-over-year suggests the low-margin business model is under pressure rather than benefiting from scale effects.

Valuation metrics present a stark disconnect between current market pricing and intrinsic value estimates, with a forward P/E ratio of 77.1x trading substantially above historical norms and sector averages implied by such high multiples. This premium appears unjustified given the DCF analysis points to a fair value significantly lower than current prices, suggesting the market is pricing in growth expectations that are not supported by recent negative revenue trends or the company's ability to generate returns exceeding its cost of capital. The discrepancy implies investors may be anticipating a turnaround in operating leverage or margin expansion that has yet to materialize in the financial statements.

Risk assessment highlights conflicting signals regarding management integrity and operational stability, as evidenced by a Beneish M-Score of -2.71 indicating low earnings manipulation risk alongside an insider flow status of $0 neutral over the past 90 days. While the lack of insider trading activity suggests no immediate flight or accumulation pressure from those with inside information, the combination of negative revenue growth and a distressed Z-score creates a scenario where downside protection is limited unless operational efficiency improves rapidly to reverse the value-destroying capital allocation trends observed in the ROIC analysis.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%8%10%
2%$51$26$13
3%$73$34$17
4%$117$46$23

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $34 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.2
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.71
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

32.2%
Gross Margin
1.8%
Net Margin
3.8%
ROIC
8.0%
WACC
ROIC − WACC Spread: -4.2%— Negative spread.
-3.2%
Revenue Growth (YoY)
-92.5%
Earnings Growth (YoY)
252.8M
Free Cash Flow
69%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

1.8%
Net Profit Margin
NI ÷ Revenue
×
0.39x
Asset Turnover
Revenue ÷ Assets
×
2.54x
Equity Multiplier
Assets ÷ Equity
=
1.8%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.54x
Debt / Equity
1.09x
Current Ratio
1.4x
Interest Coverage
2.3x
Net Debt / EBITDA
4.58%
FCF Yield
1.0B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.13
Act: $1.33
+18.0%
Q3
✓ Beat
Est: $0.95
Act: $1.37
+43.6%
Q2
✓ Beat
Est: $0.87
Act: $1.03
+18.3%
Q1
✓ Beat
Est: $0.77
Act: $0.83
+7.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.4
Forward P/E
PEG Ratio
1.37
Price/Book
2M
Avg Volume
$32.62
52W High
$19.88
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$131M
Tracked Passive Exposure
6
ETFs Holding NOG
0.22%
Avg Weight in ETFs
$61B
Total ETF AUM

When investors buy or sell ETFs like XOP or SLYV, the fund manager is mechanically forced to buy or sell NOG shares regardless of NOG's individual fundamentals. We estimate $131M of passive capital is structurally linked to NOG through 6 tracked ETFs. Passive flows have a limited but growing influence on NOG's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in NOG to visualize passive redemption contagion across ETFs and collateral stocks.

NOG Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
NOGEpicenterVTWOETFSPSMETFVDEETFXOMLow RiskCVXLow RiskCOPLow RiskSMMed RiskWMBHigh Risk
NOG Price Drop (%)0

If NOG (NOG) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Exxon Mobil Corp. (XOM) as the most exposed collateral stock, sharing 1 ETFs with NOG. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

NOG Ownership Dynamics

Ticker
NOG

Float lock-up computed from 9 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

NOG Capital Efficiency

How efficiently does NOG convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$253M
EBITDA
$1.0B
FCF Conversion
24%
Reinvestment Rate
76%
24% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
3.8%
ROIC − WACC Spread
-4.2%

NOG converts 24% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 76% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-4.2%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0744,756$24.73$1.1M
2026-05-066,368$26.65$169,707.2
2026-05-056,368$26.80$170,662.4
2026-05-046,368$26.52$168,879.36
2026-04-24237$26.90$6,375.3
2026-04-23400$26.43$10,572
2026-04-22872$25.57$22,297.04
2026-04-13927$26.94$24,973.38
2026-04-09456$28.06$12,795.36
2026-04-0730$28.47$854.1
2026-04-022,417$27.60$66,709.2
2026-03-311,567$29.91$46,868.97
2026-03-3010,836$30.82$333,965.52
2026-03-2760,920$30.41$1.9M
2026-03-262,448$29.61$72,485.28
2026-03-24156$28.60$4,461.6
2026-03-233,068$28.84$88,481.12
2026-03-165,000$27.51$137,550
2026-03-1318,800$27.61$519,068
2026-03-11126$27.53$3,468.78
2026-03-0616,866$28.34$477,982.44
2026-03-0336$27.93$1,005.48
2026-03-0255,655$27.59$1.5M
2026-02-26258$26.48$6,831.84
2026-02-252,106$27.18$57,241.08
2026-02-2329,696$28.15$835,942.4
2026-02-1916$27.36$437.76
2026-02-17731$25.96$18,976.76
2026-02-13510$25.10$12,801
2026-02-128,367$26.58$222,394.86

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare NOG to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.